Latest News in the pharma Industry

Policy & Regulation

Shire receives extension of Market Authorization in Europe for Revestive

Shire receives extension of Market Authorization in Europe for Revestive

7 Jul 2016

First therapy indicated in the EU for use in patients aged one year and above with Short Bowel Syndrome, a rare gastrointestinal condition.

Read more 
EC approves extended indication for Amgen's Kyprolis

EC approves extended indication for Amgen's Kyprolis

4 Jul 2016

Head-to-head Phase III trial demonstrated superiority of Kyprolis and dexamethasone over Velcade and dexamethasone in patients with relapsed multiple myeloma.

Read more 
Chinese authorities issue operating approval to Siegfried Nantong

Chinese authorities issue operating approval to Siegfried Nantong

30 Jun 2016

This significant site addition to Siegfried’s production network strengthens the company’s long-term competitiveness.

Read more 
FDA Advisory Committee recommends approval of Jardiance for cardiovascular indication

FDA Advisory Committee recommends approval of Jardiance for cardiovascular indication

29 Jun 2016

Endocrinologic and Metabolic Drugs Advisory Committee votes in favour of cardiovascular mortality benefit for JARDIANCE for adults with type 2 diabetes.

Read more 
BMS Opdivo receives Breakthrough Therapy Designation from FDA for advanced form of bladder cancer

BMS Opdivo receives Breakthrough Therapy Designation from FDA for advanced form of bladder cancer

27 Jun 2016

This milestone marks the sixth Breakthrough Therapy Designation for Opdivo.

Read more 
Allergan announces FDA approval of sNDA for Avycaz

Allergan announces FDA approval of sNDA for Avycaz

26 Jun 2016

Label now includes Phase III clinical data evaluating the safety and efficacy of Avycaz (in combination with metronidazole) in patients with complicated intra-abdominal infections.

Read more 
Mylan launches generic Avodart Capsules

Mylan launches generic Avodart Capsules

24 Jun 2016

Product is indicated as monotherapy for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to improve symptoms, reduce the risk of acute urinary retention and reduce the risk of the need for BPH-related sur...

Read more 
EMA starts review of medicines manufactured at Pharmaceutics International Inc.

EMA starts review of medicines manufactured at Pharmaceutics International Inc.

24 Jun 2016

Shortcomings include insufficient measures to reduce the risk of cross-contamination, as well as quality assurance.

Read more 
OPKO’S Rayaldee product receives FDA approval

OPKO’S Rayaldee product receives FDA approval

22 Jun 2016

First drug to use Catalent’s proprietary OptiShell capsule technology to achieve extended release profile.

Read more 
PaizaBio: China approves Drug Marketing Authorization Holder pilot plan

PaizaBio: China approves Drug Marketing Authorization Holder pilot plan

20 Jun 2016

Move approves the use of contract manufacturing organisations.

Read more 
Breakthrough combination for patients with skin cancer receives fast-tracked ‘yes’ from NICE

Breakthrough combination for patients with skin cancer receives fast-tracked ‘yes’ from NICE

17 Jun 2016

This represents one of the fastest ever approvals by NICE – UK patients will be the first to benefit across Europe.

Read more 
NICE denies NHS patients access to Vertex's Orkambi

NICE denies NHS patients access to Vertex's Orkambi

17 Jun 2016

“As a result of applying the wrong appraisal process, approximately 2,700 people in England who could benefit from Orkambi are being forced to continue waiting for access.”

Read more